- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
OBI Pharma (4174)
Track today's live OBI Pharma (4174) share price, performance and key data on this page with our current TPEX:4174 stock exchange information. Analyse interactive charts and historical data, check technical buy and sell signals in real time, and follow the OBI Pharma share price on the TPEX exchange. Use the dropdown to switch exchange for the 4174 share price, head to our technical summary section, which provides analysis on OBI Pharma share price buy/sell indicators using real-time data (or discuss the OBI Pharma (4174) stock price today with other investors in the OBI Pharma TWO share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current TWO:4174 share price (ISIN: TW0004174008) to enhance your trading decisions with our free investment tools and resources.
What Is the OBI Pharma Share Price Today?
The OBI Pharma share price today is 48.55.
What Is the Stock Symbol for OBI Pharma
The stock symbol (or 'ticker') for OBI Pharma is "4174."
What Stock Exchange Does OBI Pharma Trade On?
OBI Pharma is listed and trades on the TPEX stock exchange.
Is OBI Pharma a Good Stock to Buy?
Determining whether OBI Pharma (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Use the dropdown to select a relevant stock exchange for the current TWO:4174 share price (ISIN: TW0004174008) to enhance your trading decisions with our free investment tools and resources.
What Is the OBI Pharma Share Price Today?
The OBI Pharma share price today is 48.55.
What Is the Stock Symbol for OBI Pharma
The stock symbol (or 'ticker') for OBI Pharma is "4174."
What Stock Exchange Does OBI Pharma Trade On?
OBI Pharma is listed and trades on the TPEX stock exchange.
Is OBI Pharma a Good Stock to Buy?
Determining whether OBI Pharma (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
TPEX
Currency in TWD
48.55
+1.60(+3.41%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
43.00
49.85
52 wk Range
24.30
66.80
Earnings results expected today
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
43.0049.85
52 wk Range
24.3066.80
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
4174 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Suffers from weak gross profit margins
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Sell
Moving Averages
Strong Sell
Earnings
Latest Release
13/08/2026
EPS / Forecast
-1.50 / -8.80
Revenue / Forecast
15.28M / 12M
Compare 4174 to Peers and Sector
Metrics to compare | 4174 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship4174PeersSector | |
|---|---|---|---|---|
P/E Ratio | −4.2x | −5.1x | −0.2x | |
PEG Ratio | −0.11 | 0.20 | 0.00 | |
Price/Book | 4.3x | 1.5x | 2.6x | |
Price / LTM Sales | 122.4x | 61.2x | 2.8x | |
Upside (Analyst Target) | - | 0.0% | 60.9% | |
Fair Value Upside | Unlock | 26.8% | 9.5% | Unlock |
OBI Pharma, Inc., a clinical stage oncology company, researches and develops novel therapeutic agents for unmet medical needs against cancer in Taiwan and internationally. The company’s pipeline products include Adagloxad simolenin, which is in phase 3 for the treatment of triple-negative breast cancer; OBI-833 that is in phase 2 for the treatment of non-small cell lung cancer; OBI-3424, which has completed phase 2 for the treatment of liver hepatocellular carcinoma and acute lymphocytic leukemia; OBI-992 which is in phase 1 for the treatment of solid tumors; OBI-902 and OBI-904 that are in preclinical stage for the treatment of solid tumors; OBI-999 is a novel first-in-class Antibody Drug Conjugate (ADC) with a proprietary linker technology that provides a consistent Drug-to-Antibody ratio (DAR) for cancer treatment; and BsADC which is in discovery stage for the treatment of solid tumors. It also engages in investing and trading; and manufacture and wholesale of western medicines, as well as research and development of biotechnology. OBI Pharma, Inc. was founded in 2002 and is headquartered in Taipei, Taiwan.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the OBI Pharma (TPEX: 4174) Share Price Today?
The OBI Pharma stock price today is 48.55 TWD.
What Stock Exchange Does OBI Pharma (4174) Trade On?
OBI Pharma is listed and trades on the Taipei Exchange.
What Is the Ticker (Stock Symbol) for OBI Pharma?
The stock symbol (also called a 'ticker') for OBI Pharma is "4174."
What Is the Current OBI Pharma Market Capitalisation?
As of today, OBI Pharma (TPEX: 4174) market cap is 6.39B TWD.
What Is OBI Pharma's (4174) Earnings Per Share (TTM)?
The OBI Pharma EPS is currently -11.60 (Trailing Twelve Months).
When Is the Next OBI Pharma Earnings Date?
OBI Pharma's next earnings report will be released on 09/11/2026.
Is 4174 a Buy or Sell From a Technical Analyst Perspective?
Based on today's OBI Pharma moving averages and other technical indicators, the daily buy/sell signal for 4174 stock is Neutral.
How Many Times Has OBI Pharma Stock Split?
OBI Pharma has split 3 times. (See the 4174 stock split history page for full effective split date and price information.)
What is the current trading status of OBI Pharma (TPEX: 4174)?
As of 09/11/2026, OBI Pharma (4174) is trading at a share price of 48.55 TWD, with a previous close of 58.40 TWD. The stock has fluctuated within a day range of 43.00 TWD to 49.85 TWD, while its 52-week range spans from 24.30 TWD to 66.80 TWD.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.